Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Xiqin Biotechnology is a specialized life sciences company headquartered in Shanghai, China, that focuses on the distribution and technical support of high-end research instrumentation and reagents. Established in 2016, the company has become a key partner for global biotechnology leaders, most notably serving as a major distributor for 10x Genomics and Akoya Biosciences in the Chinese market. Their business core revolves around enabling advanced genomic and proteomic research, with a particular emphasis on spatial biology and single-cell sequencing technologies. Xiqin Bio provides comprehensive services including laboratory setup, technical training, and application-specific consulting to academic institutions, hospitals, and pharmaceutical R&D centers. By bridging the gap between innovative global technologies and local research needs, the company supports the development of precision medicine and drug discovery initiatives in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 西沁.